|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 590.18 USD | +0.75% |
|
-2.09% | +77.64% |
| Nov. 18 | Medpace Holdings Insider Sold Shares Worth $3,830,453, According to a Recent SEC Filing | MT |
| Nov. 18 | Medpace: From Q3 25 success to future horizons |  |
| Capitalization | 16.5B 14.25B 13.19B 12.55B 23.08B 1,460B 25.35B 156B 60.33B 699B 61.87B 60.6B 2,566B | P/E ratio 2025 * |
39.6x | P/E ratio 2026 * | 35.5x |
|---|---|---|---|---|---|
| Enterprise value | 16.09B 13.9B 12.86B 12.24B 22.5B 1,424B 24.72B 152B 58.84B 681B 60.34B 59.1B 2,502B | EV / Sales 2025 * |
6.41x | EV / Sales 2026 * | 5.49x |
| Free-Float |
83.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | +0.75% | ||
| 1 week | -1.71% | ||
| Current month | +0.90% | ||
| 1 month | +11.76% | ||
| 3 months | +28.90% | ||
| 6 months | +93.08% | ||
| Current year | +77.64% |
| 1 week | 575 |  | 608.62 |
| 1 month | 525.77 | | 625 |
| Current year | 250.05 | | 625 |
| 1 year | 250.05 | | 625 |
| 3 years | 167 | | 625 |
| 5 years | 121.34 | | 625 |
| 10 years | 21.76 | | 625 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 68 | 1992-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 50 | 2021-07-31 |
Jesse Geiger
PSD | President | 50 | 2021-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 68 | 1992-06-30 |
Robert Kraft
BRD | Director/Board Member | 54 | 2016-06-30 |
Brian Carley
BRD | Director/Board Member | 71 | 2016-06-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | -1.71% | +89.99% | +171.12% | 16.5B | |
| -1.89% | -0.90% | +3.28% | +6.65% | 47.62B | |
| -3.37% | +10.55% | +92.32% | +81.44% | 41.68B | |
| +0.54% | +1.99% | +12.77% | +2.77% | 36.81B | |
| -3.21% | +5.88% | +21.35% | +16.29% | 28.65B | |
| +2.08% | +12.51% | +28.02% | +244.46% | 13.37B | |
| +0.26% | +10.77% | +71.63% | +87.86% | 13.23B | |
| +2.89% | +2.12% | -15.09% | -25.28% | 11.95B | |
| +0.57% | -6.98% | +27.42% | - | 11.81B | |
| -2.08% | -0.86% | +26.54% | -13.53% | 12.07B | |
| Average | -0.35% | +2.72% | +35.82% | +63.53% | 23.37B | |
| Weighted average by Cap. | -1.04% | +3.49% | +35.76% | +49.88% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.51B 2.17B 2.01B 1.91B 3.51B 222B 3.86B 23.77B 9.18B 106B 9.42B 9.22B 390B | 2.81B 2.43B 2.25B 2.14B 3.93B 249B 4.32B 26.61B 10.28B 119B 10.54B 10.33B 437B |
| Net income | 436M 377M 349M 332M 610M 38.61B 670M 4.13B 1.6B 18.47B 1.64B 1.6B 67.85B | 480M 414M 383M 365M 671M 42.45B 737M 4.54B 1.75B 20.31B 1.8B 1.76B 74.59B |
| Net Debt | -409M -353M -327M -311M -572M -36.2B -629M -3.87B -1.5B -17.32B -1.53B -1.5B -63.61B | -1.07B -920M -852M -811M -1.49B -94.33B -1.64B -10.09B -3.9B -45.13B -4B -3.91B -166B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-11-18 | 590.18 $ | +0.75% | 219,108 |
| 25-11-17 | 585.76 $ | -0.73% | 156,718 |
| 25-11-14 | 590.09 $ | -0.21% | 184,581 |
| 25-11-13 | 591.32 $ | -1.05% | 236,099 |
| 25-11-12 | 597.60 $ | -0.86% | 172,240 |
Delayed Quote Nasdaq, November 18, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MEDP Stock
Select your edition
All financial news and data tailored to specific country editions
